Arcturus Therapeutics Holdings
ARCT67
$14.08arrow_drop_up1.43%$0.19
ARCT67
$14.08
arrow_drop_up1.43%| Key Stats | |
|---|---|
| Open | $14.02 |
| Prev. Close | $13.90 |
| EPS | -2.33 |
| Dividend | Non-Dividend |
| Next Earnings Date | - |
| Dividend Yield % | - |
| PE Ratio | - |
| LOW | HIGH | |
|---|---|---|
| Day Range | 13.38 | 14.25 |
| 52 Week Range | 12.74 | 45.00 |
| Ratios | |
|---|---|
| EPS | -2.33 |
| Fundamentals | |
|---|---|
| Payout Ratio | - |
| Industry average yield | 2.92% |
| Last Dividend pay date | Nov 16, 2017 |
| Dividend per share | - |
| Dividend yield forecast | - |
Stock Analysis
Technicals
Summarizing what the indicators are suggesting.
—Strong Buy
—Buy
—Neutral
—Sell
—Strong Sell
Analyst rating
An aggregate view of professional's ratings.
—Strong Buy
—Buy
—Neutral
—Sell
—Strong Sell
Stock Performance
ARCT-
US Healthcare Sector-
US Market-
warning
ARCT / Market
ARCT lose to the US Market which returned 2.09% over the last twenty four hours.warning
ARCT / Healthcare Sector
ARCT lose to the US Healthcare sector which returned 3.60% over the last twenty four hours.Arcturus Therapeutics Holdings (ARCT) Statistics
Keep an eye on Arcturus Therapeutics Holdings
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
help
How has Arcturus Therapeutics Holdings (ARCT) stock's performance compared to its sector and the market over the past year?
Over the past year, Arcturus Therapeutics Holdings (ARCT) has experienced a price change of . Compared to the Healthcare sector, which saw a change of 20.81%, Arcturus Therapeutics Holdings has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 33.16%, it has fallen short of the market average. This comparison highlights Arcturus Therapeutics Holdings 's performance relative to both its sector and the overall market over the last year.
help
What is the PE ratio of Arcturus Therapeutics Holdings (ARCT) stock?
The PE ratio for Arcturus Therapeutics Holdings (ARCT) is currently not available. This could be due to a variety of factors such as the company not having positive earnings at the moment or recent updates not being reflected.
help
What is the EPS of Arcturus Therapeutics Holdings (ARCT) stock?
The Earnings Per Share (EPS) for Arcturus Therapeutics Holdings (ARCT), calculated on a diluted basis, is -$2.33. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.
help
What is the operating margin of Arcturus Therapeutics Holdings (ARCT) stock?
The operating margin for Arcturus Therapeutics Holdings (ARCT) is -25.77%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.
help
What is the EBITDA of Arcturus Therapeutics Holdings (ARCT) stock?
The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of Arcturus Therapeutics Holdings (ARCT) is -$77.01M. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.
help
How much debt does Arcturus Therapeutics Holdings (ARCT) have?
Arcturus Therapeutics Holdings (ARCT) has a total debt of $29.42M. The net debt, which accounts for cash and cash equivalents against the total debt, is -$207.76M.